Pulmonx Q4 Earnings Call Highlights: Management Outlines Causes of US Underperformance and Plans for Growth
ByAinvest
Friday, Mar 6, 2026 6:58 am ET1min read
LUNG--
Pulmonx reported U.S. underperformance in 2025 due to internal operational and executional challenges, including disruptive territory changes and incentive design. The company completed a cost restructure, secured a $60 million credit facility, and expects to reduce annual cash burn from $32M in 2025 to $23M in 2026. Pulmonx is focusing on rebuilding U.S. momentum and advancing clinical programs to expand its total addressable market. The company expects U.S. growth to resume in the back half of 2026.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet